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ABSTRACT 
Objective:  To determine the Neuroendoscopic management of hydrocephalus in children. 
Materials and Methods:  The study was conducted at the Department of Neurosurgery, Peoples University of 
Medical and Health Science for women Nawabshah from January 2014 to May 2015. All of the patients with 
hydrocephalus diagnosed on history, clinical examination and CT scan included in the study. Subjects with co–
morbidities such as uncontrolled diabetes, cardiac diseases or uremia were excluded. Patients with age of 6 
months to 13 years either gender were included in the study. Aesculap rigid rod lens neuroendoscope with 0 
degree was utilized. Warm ringers were utilized for irrigation, a Fogarty embolectomy catheter was utilized for 
ETV. Hemostasis was accomplished with irrigation, tamponade or coagulation. Endoscopic third ventriculostomy 
(ETV) was labeled successfully when characteristics of intracranial hypertension (ICP) clinically improved and 
the size of ventricular decreased on post-operative CT scan. All the data was recorded in the Proforma. 
Results:  Thirty patients with male to female ration 2.5:1 were administered. Age ranged between 6 months and 
12 years with a mean of 22.03 months. There were 15(%) cases of Tri Ventricular Hydrocephalus, 10 cases of 
Tetra Ventricular Hydrocephalus. Two cases of Dandy Walker Hydrocephalus, one case of Asymmetrical 
Ventricles Hydrocephalus and postoperative fever occurred in two subjects. CSF leak appeared in one patient 
who was managed conservatively. No operative mortality was found.ETV worked effectively for Hydrocephalus 
treatment in 99.9% patients included in the study. 
Conclusion:  Neuroendoscopy is helpful in preventing the practice of shunts for hydrocephalus treatment in 
children, preventing its cost and complications. Neuroendoscopy is a procedure used in neurosurgery, which is 
highly frequent for the management of hydrocephalus and intra-ventricular lesions. 
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INTRODUCTION 
Hydrocephalus is the expansion in the ventricular 
system of the brain due to poor transfer of CSF 
(Cerebrospinal fluid) from its formation place to 
absorption place into systemic circulations.
1
 At present 
the most frequently practiced therapeutic options for 
hydrocephalus treatment are Neuroendoscopic surgery 
and ventriculoperitoneal shunt. Although each option 
has some benefits and drawbacks, ventriculoperitoneal 
shunt methods have the high rate of complication. 
These frequent complications can be presented as a 
well-known collection of signs and symptoms. Highest 
frequency characterized by drainage method is 
infection and obstruction, in spite of the technical 
advancement accomplished in the development of 
drainage method.
2
 Each of this complication required 
surgery to treat raising the mortality and morbidity of 
this logical thing. Neuroendoscopy is an effective 
alternative for hydrocephalus management.
3
 
Neurosurgeons have been using endoscopy since the 
early 20
th
 century. During 1918, Walter Dandy being 
among the earliest surgeons, employed endoscope for 
choroid plexectomy among four cases of 
communicating hydrocephalus.
4
 The outcomes were 
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poor, because3 of 4subjects died. Because of these 
disappointing outcomes Dandy developed a novel 
method for fenestration of the floor of the third 
ventricle via. a sub-frontalmethod.
5
 Though this 
method remained unpopular because it required an 
optic nerve sacrifice to afford it. Fay and Grant in 
1923, successfully visualized and took the photographs 
of ventricles’ interior area of a child, who had 
hydrocephalus via a cystoscope.
 6
 At the same period 
of time, a Urologist William Mixter first time in 
history, carried out an ETV. William Mixter utilized a 
urethroscope for examining the child’s ventricles who 
had obstructive hydrocephalus; and he fenestrated the 
third ventricle’s floor during this method.12 The ETV 
intended to form a fresh communication between the 
subarachnoid space and ventricular system by 
fenestration of the third ventricle’s floor. The 
developers of EVT such as; Patterson, Hoffman, Hirsh 
and Bergland, suggested that the technique should just 
be applied to the cases with non–communicating or 
obstructive hydrocephalus, among whom typical 
absorption system of CSF is yet present at arachnoid 
villi.
8
 Certainly, the literature exhibited ETV to be 
further effective when hydrocephalus is because of 
compression of fourth ventricle or aqueductal stenosis 
or aqueduct by tumors.
8
 Factors of hydrocephalus for 
example meningitis, intraventricular bleeding and 
subarachnoid bleeding have been considered by a few 
authors to exclude subjects from ETV. Though, in 
recent times these have become comparative 
contraindications taking into consideration the 
decrease of the mortality and morbidity of ETV. 
Current publication has revealed an acceptable 
outcome of ETV than VP Shunt if its symptom was 
widened to subjects with Cerebrospinal fluid infection, 
subarachnoid hemorrhage, intraventricular 
hemorrhage, normal pressure hydrocephalus (NPH), 
and further communicating hydrocephalus.
9-13
 
Gangmei et al
14
 reported a success rate of ETV up to 
73.4% in (33/45) cases with NPH and 60% in (12/20) 
cases with hydrocephalus (abnormal buildup of CSF) 
secondary to hemorrhage or infection. The most recent 
preliminary outcome of a randomized to VP-Shunt 
(with fixed-pressure valves) to ETV, exhibited that, for 
VP Shunt, the 12 month improvement rates were 
77.0%, while only 50.0% of subjects who experienced 
ETV exhibited improvement. The variance was 
significant, statistically.
15
 Thus, now it is problematic 
to support ETV as a standard or improve the 
perception of pathophysiology of non-obstructive 
hydrocephalus. Besides the etiology of hydrocephalus, 
success rates of ETV at age < 6 months are revealed to 
have greater rates failure.
8
 This study has been 
conducted to determine the Neuroendoscopic 
management of hydrocephalus in children aged 6 
months to 12 years. 
 
MATERIALS AND METHODS 
Study Design 
The current descriptive case study was conducted at 
the Neurosurgery department of Peoples University of 
Medical & Health Sciences for Women Nawabshah, 
from January 2014 to May 2015. 
 
Inclusion Criteria 
Patients with hydrocephalus diagnosed on history, 
clinical examination and CT scan included in the 
study. 
 
Exclusion Criteria 
Subjects with co–morbidity such as uncontrolled 
diabetes, cardiac diseases or uremia were excluded. 
 
Data Collection 
Patients with age of 6 months to 13 years old were 
included in the study. Aesculap rigid rod lens 
neuroendoscope with 0 degree was utilized. Warm 
ringers were utilized for irrigation, a Fogarty 
embolectomy catheter was utilized for ETV. 
Endoscopic third ventriculostomy (ETV) was labeled 
successfully when characteristics of intracranial 
hypertension (ICP) clinically improved and the size of 
ventricular decreased on post-operative CT scan. All 
the data was recorded in the Proforma. 
 
Data Analysis 
All data was used for analysis. 
 
RESULTS 
Gender 
Thirty patients with male to male ration 2.7:1 were 
managed. 
 
Age 
Age ranged 6 months to 8 Years with a mean of 22.03 
months. 
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Type of Hydrocephalus 
There were 16 (30.0%) cases of Tri Ventricular 
Hydrocephalus, 11 (36.7%) cases of Tetra Ventricular 
Hydrocephalus. 02 (6.7%) cases of Dandy Walker 
Hydrocephalus and 1 (3.3%) case of Asymmetrical 
Ventricles Hydrocephalus (Table 1). 
 
Table 1: Patients distribution according to 
demographic characteristics (n = 30). 
 
Demographic Characteristics Frequency (%) 
Age groups (years)  
> 1  09 (30%) 
1 to 3 15 (50%) 
4 to 6  05 (16.7%) 
7 to 8 01 (03.3%) 
Total  30 (100%) 
Gender   
Boys  21 (70%) 
Girls 09 (30%) 
Total  30 (100.0%) 
Hydrocephalus classification   
Tri Ventriular Hydrocephalus   16 (53.3%) 
Tetra Ventricular Hydrocephalus 11 (36.7%) 
Dandy Walker Hydrocephalus   2 (6.7%) 
A symetrical Ventricles Hydrocephalus 1 (3.3%) 
Total 30 (100.0%) 
 
Operative Procedure 
Right ETV + Septum Pellucidotomy53.3%, Right 
ETV + Septum Pellucidotomy + Irrigation 36.7%, 
septum pellucidotomy 6.7% and Asymmetrical 
Ventricles Hydrocephalus was performed in 1 case 
(Table 2). 
 
Outcome 
Management success rate was 86.7%. Postoperative 
fever occurs in 2 subjects. CSF leak appeared in one 
subject, who was managed conservatively. There was 
no operative mortality and one case failed due to 
abnormal anatomy (Table 3). 
 
Table 2:  Management procedures (n = 30). 
 
Procedure Frequency Percent 
Right ETV + Septum Pellucidotomy 16 53.3 
Right ETV + Septum Pellucidotomy 
+ Irrigation 
11 36.7 
septum pellucidotomy   2 6.7 
Asymetrical Ventricles 
Hydrocephalus 
  1 3.3 
Total 30 100.0 
 
Table 3: Neuroendoscopic management outcome 
(n = 30). 
 
Postoperative Complications Frequency (%) 
Success rate 26 (86.7%) 
Fever 2 (6.7%) 
CSF leak 1 (3.3%) 
Procedure failed 1 (3.3%) 
Total 30 (100.0%) 
 
DISCUSSION 
In our study, twenty one patients were male, and male 
to female ratio was = 2.5:1. In comparison to our 
results, study conducted by Muga et al
16
 reported that 
musculoskeletal system abnormalities highly frequent, 
after that CNS anomalies, among which the most 
frequent was hydrocephalus afterward microcephaly 
and anencephaly and later chromosomal with highly 
frequent Down’s syndrome. Polydactyl was the single 
most frequent malformation. Males were noted more 
than females, however, the variance was not 
significant, statistically. ETV has 2major purposes: the 
restoration of CSF communication between the 
subarachnoid and ventricle space; and the reduction of 
pulsatile stress via raising conformity of the 
ventricular walls.
17
 ETV was extensively used for 
hydrocephalus among children as a substitute to CSF 
shunt primarily in an effort to prevent implantation of 
foreign entity and to superiorly induce physiological 
CSF dynamics. Children with shunts depend upon 
surgery all through their lives.
18
 Therefore, the 
introduction of neuroendoscopy was enthusiastically 
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received. ETV has been a monotonous surgical 
procedure for the previous 20 years and offers a 
substitute to the CSF shunt. 
 In our study Right ETV + Septum Pellucidotomy 
was done among most of the cases. In comparison to 
our results, a study conducted by Vulkaran et al
19
 
reported that Children can most probably be successful 
with ETV, currently can be precisely identified and 
can spare the longstanding complications associated 
with CSF shunting. Another study conducted by 
Javadpour et al
20
 also reported in their results that 
throughout the follow-up phase, ETV remained 
evident among 7 (33%) of subjects (n = 21). Their 
results also suggested that selective application of 
ETV as a primary administration in babies with 
hydrocephalus is reliable and can diminish shunted 
populace of all freshly diagnosed hydrocephalic babies 
by around 21.0%. Another study conducted by Yadav 
et al
21
 also reported that ETV was rather safe and 
useful in typical birth weight full term infants, 
however in premature low birth weight infants the 
outcomes were poor. 
 The results of our study showed that management 
success rate was 86.7%. Postoperative fever occurs in 
2 subjects. CSF leak occurred in 1subject who was 
managed conventionally and no operative mortality 
was found and one case failed due to abnormal 
anatomy.  A study conducted by Brohi et al
22
 exhibited 
68.0% efficacy; which is somewhat lesser than this 
study, however no significant variance exist, 
statistically. Long period of follow-up is possibly the 
factor for slightly lesser success rate within the study 
by Brohiet al.
22
 Further studies such as Sufianov et al
23
 
recounted 71.40% efficacy; which is highly closer to 
the general efficacy in this study. In comparison to our 
results, a study conducted by Simone Peraioet et al
24
 
reported that neuroendoscopy contributes significantly 
in the longstanding administration of complex 
hydrocephalus, considerably reducing the shunt 
revision rate and the number of shunts. The total 
postoperative complication rate was 28.0% (2.90%: 
subdural collection; 8.80%: shunt malfunction; 
16.10%: shunt infection). At final clinical follow-up, 
65.0% kids had just 1 shunt, 25.0% had a twofold 
ventricular catheter, and 10.0% were shunt free. 
Similar results were also seen in a study conducted by 
de Ribaupierre et al,
25
 in which the ETV failure rates 
were 26.0% and that of VP shunt was 42.0% at follow-
up period of 5 years. The similar trend was observed in 
further series. Kulkarni et al
26
 also documented that 
the RR of ETV failure was initially greater than CSF 
shunt. Though, the risk turned gradually lower at 
around 3 months after the process, and was around 
50% the risk of shunt failure at 2 years. Other reports 
also have found similar results.
27,28
 
 
CONCLUSION 
Neuroendoscopy is helpful in preventing the practice 
of shunts for hydrocephalus treatment in children, 
preventing its cost and complications. 
Neuroendoscopy is a technique used in neurosurgery, 
which is highly frequent for the management of 
hydrocephalus and intra-ventricular lesions. However, 
the financial implications are a concern and the reason 
for its unavailability in most of the public sector 
hospitals. More similar studies are required on this 
management. 
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